Neuburgh Advisers’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,090
| Closed | -$65K | – | 946 |
|
|
2019
Q2 | $65K | Hold |
2,090
| – | – | ﹤0.01% | 842 |
|
|
2019
Q1 | $49K | Hold |
2,090
| – | – | ﹤0.01% | 853 |
|
|
2018
Q4 | $29K | Sell |
2,090
-7,590
| -78% | -$105K | ﹤0.01% | 849 |
|
|
2018
Q3 | $97K | Buy |
9,680
+6,182
| +177% | +$61.9K | ﹤0.01% | 809 |
|
|
2018
Q2 | $71K | Buy |
+3,498
| New | +$71K | ﹤0.01% | 821 |
|